EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6-Reference-Cited by-同舟云学术

EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6

Published:2020-09-09 Issue:21 Volume:80 Page:4620-4632
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Patil Shilpa^ORCID,Steuber Benjamin,Kopp Waltraut,Kari Vijayalakshmi,Urbach Laura^ORCID,Wang Xin^ORCID,Küffer Stefan^ORCID,Bohnenberger Hanibal,Spyropoulou Dimitra,Zhang Zhe^ORCID,Versemann Lennart,Bösherz Mark Sebastian,Brunner Marius,Gaedcke Jochen,Ströbel Philipp,Zhang Jin-San^ORCID,Neesse Albrecht,Ellenrieder Volker,Singh Shiv K.^ORCID,Johnsen Steven A.^ORCID,Hessmann Elisabeth

Funder

German Cancer Aid

Wilhelm-Sander-Stiftung

DFG

MWK

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilevel Regulation of NF‐κB Signaling by NSD2 Suppresses Kras‐Driven Pancreatic Tumorigenesis;Advanced Science;2024-06-18

2. Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer;Cancer Letters;2024-04

3. New clinical trial design in precision medicine: discovery, development and direction;Signal Transduction and Targeted Therapy;2024-03-04

4. An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies;Gastroenterology;2024-02

5. Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state;Cell Death & Disease;2024-01-26